These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 34939881)

  • 1. Graves Disease Following the SARS-CoV-2 Vaccine: Case Series.
    Weintraub MA; Ameer B; Sinha Gregory N
    J Investig Med High Impact Case Rep; 2021; 9():23247096211063356. PubMed ID: 34939881
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of Graves' Disease After SARS-CoV-2 mRNA Vaccination: A Case Report and Literature Review.
    Lui DTW; Lee KK; Lee CH; Lee ACH; Hung IFN; Tan KCB
    Front Public Health; 2021; 9():778964. PubMed ID: 34888290
    [No Abstract]   [Full Text] [Related]  

  • 3. Graves' disease after exposure to the SARS-CoV-2 vaccine: a case report and review of the literature.
    Takedani K; Notsu M; Ishiai N; Asami Y; Uchida K; Kanasaki K
    BMC Endocr Disord; 2023 Jun; 23(1):132. PubMed ID: 37316819
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Graves' disease following administration of second dose of SARS-CoV-2 vaccine.
    Goblirsch TJ; Paulson AE; Tashko G; Mekonnen AJ
    BMJ Case Rep; 2021 Dec; 14(12):. PubMed ID: 34969799
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SARS-CoV-2 mRNA Vaccination and Graves' Disease: A Report of 12 Cases and Review of the Literature.
    Chee YJ; Liew H; Hoi WH; Lee Y; Lim B; Chin HX; Lai RTR; Koh Y; Tham M; Seow CJ; Quek ZH; Chen AW; Quek TPL; Tan AWK; Dalan R
    J Clin Endocrinol Metab; 2022 May; 107(6):e2324-e2330. PubMed ID: 35235663
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The British variant of the new coronavirus-19 (Sars-Cov-2) should not create a vaccine problem.
    Conti P; Caraffa A; Gallenga CE; Kritas SK; Frydas I; Younes A; Di Emidio P; Tetè G; Pregliasco F; Ronconi G
    J Biol Regul Homeost Agents; 2021; 35(1):1-4. PubMed ID: 33377359
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thyrotoxicosis following SARS-COV-2 vaccination: a case series and discussion.
    Pla Peris B; Merchante Alfaro AÁ; Maravall Royo FJ; Abellán Galiana P; Pérez Naranjo S; González Boillos M
    J Endocrinol Invest; 2022 May; 45(5):1071-1077. PubMed ID: 35015288
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Graves' orbitopathy post-SARS-CoV-2 vaccines: report on six patients.
    Abeillon-du Payrat J; Grunenwald S; Gall E; Ladsous M; Raingeard I; Caron P
    J Endocrinol Invest; 2023 Mar; 46(3):617-627. PubMed ID: 36378488
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Case Report of Concurrent Graves' Disease and Subacute Thyroiditis Following SARS-CoV-2 Vaccination: An Autoimmune/Inflammatory Syndrome (ASIA).
    Taşkaldıran I; Altay FP; Bozkuş Y; İyidir ÖT; Nar A; Tütüncü NB
    Endocr Metab Immune Disord Drug Targets; 2023; 23(2):242-246. PubMed ID: 35726807
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Four cases of Graves' disease following viral vector severe acute respiratory syndrome corona virus-2 (SARS-CoV-2) vaccine.
    Chaudhary S; Dogra V; Walia R
    Endocr J; 2022 Dec; 69(12):1431-1435. PubMed ID: 35979558
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New-onset Thyroid Eye Disease after COVID-19 Vaccination in a Radioactive Iodine-Treated Graves' Disease Patient: A Case Report and Literature Review.
    Im Teoh JH; Mustafa N; Wahab N
    J ASEAN Fed Endocr Soc; 2023; 38(1):125-130. PubMed ID: 37252417
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autoimmune and inflammatory thyroid diseases following vaccination with SARS-CoV-2 vaccines: from etiopathogenesis to clinical management.
    Caron P
    Endocrine; 2022 Dec; 78(3):406-417. PubMed ID: 35763241
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New Onset or Deterioration of Thyroid Eye Disease After mRNA SARS-CoV-2 Vaccines: Report of 2 Cases and Literature Review.
    Mohamed A; Tzoulis P; Kossler AL; Dosiou C
    J Clin Endocrinol Metab; 2023 Mar; 108(4):979-985. PubMed ID: 36251747
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Subacute Thyroiditis Following SARS-CoV-2 Vaccines: Six Cases Report and Review of the Literature.
    Kurtulmus N; Kayikci K
    Horm Metab Res; 2022 Aug; 54(8):556-561. PubMed ID: 35318621
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased incidence of Graves' disease during the SARS-CoV2 pandemic.
    Barajas Galindo DE; Ramos Bachiller B; González Roza L; García Ruiz de Morales JM; Sánchez Lasheras F; González Arnáiz E; Ariadel Cobo D; Ballesteros Pomar MD; Rodríguez IC
    Clin Endocrinol (Oxf); 2023 May; 98(5):730-737. PubMed ID: 36510647
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dynamics of Antibody Response to BNT162b2 mRNA COVID-19 Vaccine: A 7-Month Follow-Up Study.
    Olariu TR; Ursoniu S; Marincu I; Lupu MA
    Medicina (Kaunas); 2021 Dec; 57(12):. PubMed ID: 34946275
    [No Abstract]   [Full Text] [Related]  

  • 17. SARS-CoV-2 vaccine may trigger thyroid autoimmunity: real-life experience and review of the literature.
    Ruggeri RM; Giovanellla L; Campennì A
    J Endocrinol Invest; 2022 Dec; 45(12):2283-2289. PubMed ID: 35829989
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Two Cases of Autoimmune Thyroid Disorders after COVID Vaccination in Dialysis Patients.
    Lioulios G; Tsouchnikas I; Dimitriadis C; Giamalis P; Pella E; Christodoulou M; Stangou M; Papagianni A
    Int J Mol Sci; 2022 Sep; 23(19):. PubMed ID: 36232790
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Successful mRNA SARS-Cov-2 vaccine rechallenge after a first episode of immune thrombocytopenic purpura.
    Chanut M; Jaidi R; Kohn M; Grange T; Brones C; Lombion N; Rousselot P; Longval T
    Platelets; 2022 May; 33(4):652-653. PubMed ID: 35225144
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effectiveness of Pfizer-BioNTech and Moderna Vaccines in Preventing SARS-CoV-2 Infection Among Nursing Home Residents Before and During Widespread Circulation of the SARS-CoV-2 B.1.617.2 (Delta) Variant - National Healthcare Safety Network, March 1-August 1, 2021.
    Nanduri S; Pilishvili T; Derado G; Soe MM; Dollard P; Wu H; Li Q; Bagchi S; Dubendris H; Link-Gelles R; Jernigan JA; Budnitz D; Bell J; Benin A; Shang N; Edwards JR; Verani JR; Schrag SJ
    MMWR Morb Mortal Wkly Rep; 2021 Aug; 70(34):1163-1166. PubMed ID: 34437519
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.